Unsurprisingly, Microsoft (NASDAQ:MSFT) continues to soar higher and boasts a market cap above $3 trillion. The tech giant’s ascent has inspired many investors to pursue stocks that can someday reach the $1 trillion milestone.  Finding long-term investments and letting time take its course can be a winning strategy. However, you have to pick the right assets
0 Comments
Without a doubt, the meme-stock craze is over for the most part. Nearly all of the former meme favorites, from Gamestop (NYSE:GME) to Ocugen (NASDAQ:OCGN) to Vinco Ventures (OTC:BBIG), have lost the lion’s share of their peak values and are currently struggling, both from a fundamental perspective and in terms of their stock prices. Still,
0 Comments
Palantir (NYSE:PLTR) stock jumped 25% last Tuesday after the data analytics firm announced a surge in AI-related demand. U.S. commercial revenues rose 70% year over year, driven by a 55% increase in customer count and rising contract values. “AI has radically recalibrated customer expectations for software,” said chief technology officer Shyam Sankar during the company’s
0 Comments
Several positive signs point to potential prosperity as I look at the current financial landscape. The stock market is surging to new highs, with the S&P 500 reaching record territory and the Nasdaq index not far behind. Speculative investments like Bitcoin (BTC-USD) have also been rallying. This shows investors are feeling optimistic about the future. More importantly, key economic
0 Comments
2024 might be the year space stocks break through years of shakiness and pre-revenue indecision. Already, we’re seeing major companies like SpaceX, Rocket Lab USA (NASDAQ:RKLB), and AST SpaceMobile (NASDAQ:ASTS) rack up win after win. We’re even seeing companies like Amazon (NASDAQ:AMZN) enter the space race through its Kuiper Systems initiative. But, though space stocks
0 Comments
February triggered a rollercoaster ride through the stock market’s twists and turns. Amidst the cacophony of growth stocks to sell, three names echo the market with a hint of fundamental caution. Once labeled castles of value potential, these growth stocks stand at a dangerous crossroads. From the bustling aisles of automotive retail to the lofty
0 Comments
In this article JPM Follow your favorite stocksCREATE FREE ACCOUNT Over two thousand attendees are descending on the Fontainebleau Hotel in Miami Beach for the annual Exchange ETF conference. To entice participants, the organizers rented out the entire LIV Nightclub Miami at the hotel for a Super Bowl party Sunday night. While much of the conference
0 Comments
Cybersecurity has become a paramount concern for businesses and governments alike. According to Check Point research, 2023 was the year of mega ransomware, with 1 in 10 organizations worldwide hit by an attempted attack. As cyber-attacks become more complex, the demand for effective solutions from the best cybersecurity stocks to buy is surging. Last year,
0 Comments
The banking system has run into a fresh crisis, leaving several bank stocks to sell. Shares of New York Community Bancorp (NYSE:NYCB) plunged recently following a massive earnings miss and credit rating downgrade. This unleashed broader concerns about the state of the American regional banking system, particularly regarding credit quality and loans in the commercial
0 Comments
Midway through the current earnings reporting period, companies have been delivering results exceeding market expectations. As we forge ahead, now is the right time to discuss which stocks to watch this week. A trend observed during this earnings season is the increase in stock buybacks, a strategy executives employ to goose stock prices. So far
0 Comments
The e-commerce sector has been a rollercoaster over the past few years, thanks to the ripples created by the pandemic. Many former high-flying stocks now sit at depressed levels after the temporary Covid-19 boom ended and more normal growth resumed. This cooldown may have made it seem like the potential of this sector had been
0 Comments
The unpredictable nature of the biotech industry, which frequently flirts with failure, underscores the inherent risks and rewards associated with doomed biotech stocks. The journey from drug discovery to market approval is notoriously long and uncertain. The road often exceeds a decade, with the approval process varying significantly by drug type. This complexity, coupled with
0 Comments